2. Semperit at a glance
Investor Presentation November 2016 I Investor Relations2
Solid balance-
sheet structure
39%
equity ratio
EUR 915
million revenue
EUR 67
million EBIT
Leading market position
with strong brands in the Industrial
and Medical Sectors for more than
190 years
Balanced portfolio
Semperflex Sempertrans Semperform Sempermed
7,053 employees
Worldwide presence
Distribution in more
than 100 countries
22 production sites
worldwide
Note: values stated are for FY 2015
3. Investment Rationale (p. 4)
Outlook (p. 21)
Appendix (p. 24)
Agenda
3
Operational Development and Financial Performance (p. 11)
Investor Presentation November 2016 I Investor Relations
4. Investment Rationale
5 reasons to invest in Semperit
1. Strong position in megatrend-driven markets
2. Profitable growth based on a balanced portfolio
3. Long standing application and process engineering tradition,
proven M&A track record
4. High earnings capacity and strong balance sheet
5. Market leading brands, customer focused approach and
globally diversified sales network
4 Investor Presentation November 2016 I Investor Relations
5. 1. Strong position in megatrend-driven markets
Worldwide energy demand
Population growth
Worldwide urbanisation
Global megatrends
+33% to 9.6 billion by 2050
66% urban population
by 2050 (2014: 54%)
+30% by 2035
Medical Sector: Growth market Healthcare
Rising prosperity and
improving hygienic
standards in emerging
markets
Increasing life
expectancy and shift in
the age pyramid in
mature markets
Ø global growth of
glove market
5-6% p.a.
Use of examination gloves
per capita per year
60 - 70
25 - 3010 - 20
Asia South America Europe USA
Source: Semperit
150 - 160
Sempermed
Examination gloves
Globally leading position
Surgical gloves
Leading position in Europe
5
Market impact & growth drivers Products & market position
Industrial Sector:
industrialisation & investments in infrastructure
On-going industrialisa-
tion and infrastructure
investments
Expansion of mining
industry
Growing construction
business
Rising demand for
Semperflex,
Sempertrans and
Semperform
products
Global construction market
until 2030 (in USD trillion)
Source: Global Construction 2030
8.4
15.5
2015 2030
+85%
Semperflex
Sempertrans
Semperform
Hydraulic hoses
# 3 globally,
leader in hose only
Industrial hoses
# 2-3 in Europe
Conveyor belts
Top Tier / one of the
worldwide leading suppliers
Handrails: leading position
Window profiles:
European player
Cable car rings and
ski foils: leading position
Investor Presentation November 2016 I Investor Relations
6. 2. Profitable growth based on a balanced portfolio
Ambitious growth strategy …
True global player through expansion in growth markets
Capacity expansions and selected acquisitions
Customer proximity, market orientation and innovation strength
High performance organisation
Growth targets
Double digit volume growth 2015-2020 (CAGR)
… based on stability through diversification
Stable, largely non-cyclical growth
Expansion of leading global position
Strengthen market position in medical
and industrial/consumer goods areas
Medical
Sector
Managing industrial cycles and
on-going high profitability
Leading position in selected niches
Grow and maintain market positions
Industrial
Sector
Revenue: Accelerated growth since 2010
in EUR m
463 477 515
574 608 655
588
689
820 829
906 858
915
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014* 2015
CAGR
+4.0%
Revenue growth and high earnings
in %
Source: World Bank, Semperit
Group EBITDA
margin
Industrial Sector:
Revenue Growth in%
Medical Sector:
Revenue Growth in%
GDP Growth
World in %
CAGR
+5.8%
16.3% 13.4% 13.1% 14.6% 11.9%
* restated
6
4.0 2.8 3.1 2.4 3.3
16.6 17.4
3.2
13.4
-12.4
17.8 20.2
-0.8
5.9
1.3
9.1
2010 2011 2012 2013
2014*
10.5%
2015
3.13.4
Investor Presentation November 2016 I Investor Relations
7. 3. Long standing application and process engineering tradition,
proven M&A track record
High performance organisation for accelerated growth
Long-standing engineering know-how dates back to 1824
Strong track record in high-quality production and innovative products
Growth-orientated organisation to manage organic growth and acquisitions
Latexx Partners acquisition in 2012
Takeover of Malaysian gloves producer in 2012,
#6 in the world
Revenue 2011: EUR 104m
Employees 2011: >2,000
Expansion of the site in Kamunting with a new glove factory
Investment volume: EUR 50m
Production capacity: Doubling to about 12 billion units of
gloves per year (from 6 billion units)
Leeser acquisition in 2015
Takeover of leading German manufacturer of high-quality
rubber seals in 2015
Revenue 2014: EUR 37m
Employees 2014: >200
Acquisition strengthens market position and had an
immediate positive effect on earnings situation of Semperform
Integration is proceeding successfully, first synergies
already achieved
7 Investor Presentation November 2016 I Investor Relations
8. 4. High earnings capacity and strong balance sheet
Sophisticated Financial Engineering
Focused financing policy
Active cost and raw materials management
Cost awareness and rigid cost controlling on all levels
Optimised capital structure
Adaptation of pay-out ratio to about 50% of earnings after tax
(provided the performance and development of the company
permit it)
Strong cash generation and attractive dividend policy
Strong balance sheet and high cash position
Equity Ratio
in %
Cash and cash equivalents
in EUR m
29.4
106.7
137.2
71.5
59.8
2011 2012 2013 2014 2015
Operating Cash flow
in EUR m
Dividend per share
in EUR
1) 0.90 basic dividend + 0.30 anniversary bonus
2) 1.10 basic dividend + 4.90 one-time special
0.8 0.8 1.2
6.0
1.2
2011 2012 2013 2014 2015
61.5
49.3 48.3
53.7
38.7
2011 2012 2013 2014 2015
97.9
133.3
182.6
115.6
126.4
2011 2012 2013 2014 2015
1)
2)
8 Investor Presentation November 2016 I Investor Relations
9. 5. Market leading brands, customer focused approach and
globally diversified sales network
Products
• Leading Sempermed brands with
broad product portfolio
• OEM production for customers worldwide
Distribution
• Multi-channel distribution capabilities with
sales offices in Europe, North & South America
and Asia
Products
• Diversified product range in attractive niches
• From basic to premium products to
tailor-made / project business
Distribution
• Focus on high reputation customers
• Strong partners in wholesale
Medical Sector: Revenue by region
Europe
55%
Asia, Africa, other
10%
North & South America
35%
FY 2015 in %
Industrial Sector: Revenue by region
Europe
74%
Asia, Africa, other
15%
North & South America
11%
FY 2015 in %
9 Investor Presentation November 2016 I Investor Relations
10. Investment Rationale (p. 4)
Outlook (p. 21)
Appendix (p. 24)
Agenda
10
Operational Development and Financial Performance (p. 11)
Investor Presentation November 2016 I Investor Relations
11. Solid development despite weak market situation
Solid development through satisfying capacity utilisation and
sales activities
Industrial sector with volume growth and further gains in
market share despite very difficult markets
Medical Sector: Focus on core markets as a consequence
of challenging price and cost situation as well as ongoing
Thailand JV dispute
Predicted drop in revenue and operational earnings
Revenue decreases by -6.4% to EUR 647.6 million
EBITDA -4.2% and EBIT -13.5%1)
Net profit negatively affected by higher financial and tax
expenses
Sound Industrial Sector limits
negative effects of weak Medical Sector
Revenue by segment Q1-3 2016 (vs. Q1-3 20151))
Sempermed
40% (43%)
Semperform
19% (17%)
Sempertrans
17% (18%)
Semperflex
24% (22%)
Europe
69% (65%)
Asia, Africa, others
12% (13%)
North and South America 19% (22%)
Revenue by region Q1-3 2016 (vs. Q1-3 2015)
1) Values for 2015 restated
11 Investor Presentation November 2016 I Investor Relations
12. Still small volume growth despite economic
headwind and continued mining downturn
Margins under pressure due to subdued
market demand and price competition
Satisfactory utilisation of all production
sites
Volume growth and increase of market
share in all Business Units
Hydraulic hoses: Good utilisation in
challenging market environment
Industrial hoses: New capacities highly
utilised due to strong sales performance
Semperflex: Strong performance
Sempertrans: Competing successfully in very challenging markets
Q1-3 2016 vs. Q1-3 20151)
1) Values for 2015 restated
SemperflexSempertrans
-10%Market
EBIT
EBITDA
Revenue
-15%Market
EBIT
EBITDA
Revenue
-1.7%
-2.3%
-4.4%
-6.1%
-12.9%
-18.1%
12 Investor Presentation November 2016 I Investor Relations
13. Market share gains in decreasing markets
Profiles: successful market entry in USA;
market share gains in Western and Central
Europe compensated decline in Russia;
Handrails: business benefits from strong
After-Sales-Market
Semperform: Stable development
Sempermed: Focus on core markets
Semperform
-2%Market
EBIT
EBITDA
Revenue
1) Values for 2015 restated
2) EBITDA and EBIT in 2015 was positively influenced by one-time bad will effect from acquisition of Leeser (EUR 3.2m).
+3.4%
-4.1%
-14.5%
13
Q1-3 2016 vs. Q1-3 20151)
2)
Global glove market still growing but all
producers affected by margin squeeze
Thailand JV and start-up costs in Malaysia
put pressure on earnings
Focus on core markets Europe and
North America
Cost reduction programme and efficiency
improvements continued
Sempermed
+5%
n.a.
-49,6%
-12.9%
Market
EBIT
EBITDA
Revenue
-78.1%
2)
Investor Presentation November 2016 I Investor Relations
14. Q1-3 2016: Slight drop in revenue, stable margins
1) Values for 2015 restated
2) Attributable to the shareholders of Semperit AG Holding
in EUR m
Q1-3 2016
Q1-3 20151)
(restated)
%
Revenue 647.6 692.1 -6.4%
EBITDA 72.2 75.4 -4.2%
EBIT 46.7 53.9 -13.5%
Earnings after tax 23.4 40.1 -41.6%
Profitability
EBITDA margin 11.1% 10.9% +0.2 PP
EBIT margin 7.2% 7.8% -0.6 PP
Earnings per share in EUR2) 1.14 1.95 -41.6%
Key Financials Semperit Group1)
14 Investor Presentation November 2016 I Investor Relations
15. Development of revenue and EBIT per quarter
17.7
21.0
12.8
15.2
Q4
Q3
Q2
Q1 18.6
17.6
66.7
20151)
10.4
2016
46.7
7.0%
9.0%
7.3%
= EBIT margin
15
20151)
Q1 219.5
647.6
2016
Q4
Q3
219.2
208.9
914.7
217.5
233.4
241.3
222.6
5.8%
Revenue per quarter
in EUR m
EBIT per quarter
in EUR m
8.5%
1) Values for 2015 restated
8.0%
5.0%
Q2
Investor Presentation November 2016 I Investor Relations
16. Challenging market conditions in all sectors
-38.4
647.6
SempermedSemperform
4.0
Sempertrans
-7.4
Semperflex
-2.7
Q1-Q3 2015
-6.4%
692.1-6.2m
Industrial Sector
Q1-Q3 2016
Revenue by segment Q1-3 2016 vs. Q1-3 2015
in EUR m
-12.9%
Industrial Sector Medical Sector
-1.7% -6.1% +3.4%
-1.6%
= % change
16 Investor Presentation November 2016 I Investor Relations
17. Strong EBIT margins in Industrial Sector
53.9
-6.6m
Industrial Sector
Q1-Q3 2016
46.7
Corporate
Center
10.5
Sempermed
-11.2
Semperform
-2.6
-1.4
Q1-Q3
20151)
Semperflex Sempertrans
-2.6
-13.5%
EBIT by segment Q1-3 2016 vs. Q1-3 20151)
in EUR m
7.2%7.8%
= EBIT margin
-0.3%19.9% 10.2% 12.4%
14.7%
Industrial Sector Medical Sector
1) Values for 2015 restated
17 Investor Presentation November 2016 I Investor Relations
18. CAPEX and Working Capital Overview
= Trade Working Capital
in % of LTM revenues
-14.0%
Other
Sempermed
Semperform
Sempertrans
Semperflex
Q1-Q3 2016
44.3
4.4
18.5
8.2
3.3
9.9
Q1-Q3 2015
51.5
4.7
23.8
5.4
6.4
11.2
CAPEX per Segment
in EUR m
Components of Working Capital
in EUR m
31 Dec 2015
160.6
-100.7
125.5
135.7
Trade receivables
Trade payables
+3.0%
Inventories
30 Sept 2016
165.3
-94.0
126.0
133.3
17.6% 19.1%
18 Investor Presentation November 2016 I Investor Relations
19. 141m EUR issued in 3 currencies:
US-Dollar / Polish Zloty / Czech Crown
Maturities of 3, 5 and 7 years
Currencies for important procurement, production and
sales markets
Funds are used, among other things, to re-finance existing
financial liabilities and to ensure further expansion of
production sites
Subscribed by European and Asian investors
Original placement volume was increased significantly
Pricing was at the lower end
Interest rate of slightly above 2% on average for Corporate
Schuldschein loans issued in November 2016
Total average interest rate for Semperit Group going
forward is about 2%
Net debt / EBITDA of 2.32x as of 30 September 2016
Corporate Schuldschein Loans issued in November 2016
19
Favourable capital markets used to
diversify financing structureCurrency Split
Czech Crown
14%
Polish Zloty
23%
US-Dollar
63%
Maturity split
5 and 7 years
67%
3 years
33%
Investor Presentation November 2016 I Investor Relations
20. Investment Rationale (p. 4)
Outlook (p. 21)
Appendix (p. 24)
Agenda
20
Operational Development and Financial Performance (p. 11)
Investor Presentation November 2016 I Investor Relations
21. Outlook 2016: Challenging market conditions weigh on
operational development
Continued moderate
economic recovery
expected in the
industrialised countries
Heterogeneous picture in
emerging and developing
countries
No signs of stimulation of
industry and investments
in China, Russia and
Eastern Europe
Moderate recovery of the
global economy in 2016
Operational results expected to be below prior year:
EBITDA about -10%, EBIT about -20%
Risk factors: uncertain outlook for commodity prices and currency risks
Industrial Sector
Semperflex: Relatively stable, better than market,
strong market position and strategic partnerships mitigate cyclicality
Sempertrans: Cyclical decreasing demand,
price pressure intensified, development in accordance with market
Semperform: Relatively stable,
market share gains in decreasing markets,
globalisation of profile business
Medical Sector
Focus on core markets Europe and North America
Efficiency, optimisation and cost cutting
measures under way
Commissioning of the new production
capacities in Malaysia
Negative impact from joint venture in Thailand
likely to continue
Markets put pressure on operational development
Growth targets
Average double-digit
volume growth 2015-
2020 (CAGR)
21 Investor Presentation November 2016 I Investor Relations
22. Contact and financial calendar
22
Financial Calendar 2017
23/3/2017 Publication of 2016 annual financial
statements and press conference
26/4/2017 Annual General Meeting
2/5/2017 Ex-dividend day
4/5/2017 Dividend payment day
16/5/2017 Report on Q1 2017
17/8/2017 Report on H1 2017
16/11/2017 Report on Q1-3 2017
Investor Relations Semperit Group
Stefan Marin, Head of Investor Relations
investor@semperitgroup.com
+43 1 79777 - 210
www.semperitgroup.com/en/ir
Modecenterstrasse 22
1031 Vienna, Austria
Disclaimer
The information provided in this presentation does not constitute an offer for the sale of securities nor an invitation to submit
an offer to purchase shares of Semperit AG Holding, but exclusively serves information purposes. Rounding of differences in
the totalling of rounded amounts and percentages may arise from the automatic processing of data.
The forecasts, plans and forward-looking statements contained in this presentation are based on the knowledge and
information available and the assessments made at the time that this report was prepared. As is true of all forward-looking
statements, these statements are subject to risk and uncertainties. As a result, the actual events may deviate significantly
from these expectations. No liability whatsoever is assumed for the accuracy of projections or for the achievement of planned
targets or for any other forward-looking statements.
Investor Presentation November 2016 I Investor Relations
23. Investment Rationale (p. 4)
Outlook (p. 21)
Appendix (p. 24)
Agenda
23
Operational Development and Financial Performance (p. 11)
Investor Presentation November 2016 I Investor Relations
24. Composition of Financial Results
24
Financial result Q1-3 2015
in EUR m
-5.0
-4.6
-4.2
-22.2
26.0
Financial
income incl.
FX gains and
interest income
12.2
Interest expenses
-12.7
-4.7
Profit/loss attribu-
table to redeem-
able non-con-
trolling interests
-5.5
Financial
expenses incl.
FX losses and
other expenses
-14.7
Financial
result
Financial result Q1-3 2016
in EUR m
Q1-3 2015: Financial result
primarily influenced by FX gains
Q1-3 2016: Negative impact of
FX losses (mainly in Q1 2016)
and higher borrowing costs on
financial result
Development of financial result
Investor Presentation November 2016 I Investor Relations
25. In EUR m
Revenue
EBITDA
EBITDA margin
EBIT
EBIT margin
Earnings after tax
Earnings per share in EUR3)
Investments
Employees
(at reporting date)
Group and Sectors: Q1-3 2016 vs. Q1-3 2015
Q1-3 2016
Q1-3 2015
restated2) %
389.3 395.5 -1.6%
71.7 75.6 -5.1%
18.4% 19.1% -0.7 PP
57.1 63.7 -10.3%
14.7% 16.1% -1.4 PP
21.3 23.0 -7.4%
3,576 3,583 -0.2%
Industrial Sector Medical Sector
Q1-3 2016
Q1-3 2015
restated2)
%
258.3 296.7 -12.9%
9.8 19.4 -49.6%
3.8% 6.5% -2.7 PP
-0.9 10.3 –
-0.3% 3.5% -3.8 PP
18.5 23.8 -22.1%
3,232 3,595 -10.1%
Q1-3 2016
Q1-3 2015
restated2)
%
647.6 692.1 -6.4%
72.2 75.4 -4.2%
11.1% 10.9% +0.2PP
46.7 53.9 -13.5%
7.2% 7.8% -0.6 PP
23.4 40.1 -41.6%
1.14 1.95 -41.6%
44.3 51.5 -14.0%
7,028 7,303 -3.8%
Semperit Group1)
1) Including Corporate Center (Holding, central functions, special projects): Costs of EUR 9.6m in Q1-3 2016 (EUR 20.1m in Q1-3 2015)
2) Values for 2015 restated 3) Attributable to shareholders of Semperit AG Holding
25 Investor Presentation November 2016 I Investor Relations
26. Semperit Group per quarter
in EUR m FY 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 FY 2015 Q1 2016 Q2 2016 Q3 2016
Revenue 858.3 217.5 233.4 241.3 222.6 914.7 219.5 219.2 208.9
EBITDA 101.9 21.8 28.5 25.1 20.8 96.2 26.7 26.1 19.4
EBITDA margin 11.9% 10.0% 12.2% 10.4% 9.4% 10.5% 12.2% 11.9% 9.3%
EBIT 63.8 15.2 21.0 17.7 12.8 66.7 18.6 17.6 10.4
EBIT margin 7.4% 7.0% 9.0% 7.3% 5.8% 7.3% 8.5% 8.0% 5.0%
Financial result -11.5 1.0 -5.2 -0.8 -3.0 -8.0 -5.9 -4.1 -2.7
Earnings after
tax
37.8 12.6 12.7 14.7 6.3 46.4 10.1 7.7 5.5
Earnings per
share in EUR2) 1.85 0.61 0.62 0.72 0.31 2.26 0.49 0.38 0.27
Key Financials Semperit Group1)
1) Values for 2014 and 2015 restated
2) Attributable to shareholders of Semperit AG Holding
26 Investor Presentation November 2016 I Investor Relations
29. Solid balance sheet structure and financial flexibility
Balance sheet structure 30 September 2016
Balance sheet total: EUR 969 m
Equity
Fixed
assets
Inventories
Trade
receivables
Cash and cash
equivalents
Liabilities from
redeemable non-
controlling interests
Provisions incl.
social capital
Other liabilities
incl. deferred taxes
Current assets
Corporate
Schuldschein loan
Liabilities to banks
Cash and cash equivalents of EUR 131m despite
investment programme and optimisation of capital
structure
Financial liabilities:
Corporate Schuldschein loan of EUR 133m
Net debt of EUR 216m
Net debt / EBITDA of 2.32x
Equity ratio of 37%
Financial profile as of 30 September 2016
555
361
131
133
133
48
70
126
214
143
Equity & LiabilitiesAssets
23
29 Investor Presentation November 2016 I Investor Relations
30. Key figures consolidated income statement
Key figures income statement (1/2)
in EUR m 2008 2009 2010
2011
restated1)
2012 2013
2014
restated2)
2015
restated2)
Q1-3
2016
Revenue 655.3 588.1 689.4 820.0 828.6 906.3 858.3 914.7 647.6
Changes inventories 5.0 -9.8 13.6 2.8 -1.9 9.4 -15.3 6.8 1.4
Own work capitalised 1.4 0.9 0.8 0.8 1.6 1.0 3.3 6.2 3.1
Other operating
income
25.1 22.5 38.0 33.8 32.8 24.4 18.5 9.1 6.2
Material costs -381.9 -297.0 -410.2 -513.1 -501.0 -510.7 -487.7 -555.8 -377.8
Personnel expenses -109.3 -99.7 -109.9 -117.9 -127.4 -152.8 -151.0 -164.8 -128.3
Other operating
expenses
-107.7 -102.2 -109.5 -116.6 -124.2 -145.8 -132.3 -137.1 -85,0
Share of profits from
joint ventures and
associated
companies
0.1 0.1 0.2 0.2 0.3 0.6 8.1 17.1 5.0
EBITDA 87.9 102.8 112.3 110.0 108.7 132.5 101.9 96.2 72.2
Depreciation -29.2 -33.2 -29.9 -29.7 -36.2 -44.7 -38.1 -29.5 -25.6
EBIT 58.7 69.6 82.3 80.4 72.5 87.8 63.8 66.7 46.7
30
1) Values for 2011 restated (see Annual Report 2012, Notes 2.18), values for 2010 not restated.
2) Values for 2014 and 2015 restated
Investor Presentation November 2016 I Investor Relations
31. Key figures consolidated income statement
Key figures income statement (2/2)
in EUR m 2010
2011
restated1)
2012 2013
2014
restated3)
2015
restated3)
Q1-3 2016
EBIT 82.3 80.4 72.5 87.8 63.8 66.7 46.7
Financial income 1.9 1.7 2.2 1.9 1.4 29.2 12.2
Financial expenses -0.3 -0.5 -1.2 -4.0 -5.0 -31.8 -20.2
Profit/loss attributable to
redeemable non-
controlling interests
-21.0 -14.7 -15.0 -14.8 -7.8 -5.4 -4.7
Financial result -19.2 -13.4 -14.0 -16.9 -11.5 -8.0 -12.7
Earnings before tax 63.1 66.9 58.5 70.9 52.3 58.8 33.9
Income taxes -17.7 -15.2 -12.2 -16.0 -14.5 -12.4 -10.5
Earnings after tax 45.4 51.8 46.2 54.9 37.8 46.4 23.4
Earnings per share in
EUR2) 2.21 2.52 2.25 2.65 1.85 2.26 1.14
31
1) Values for 2011 restated (see Annual Report 2012, Notes 2.18), values for 2010 not restated.
2) Attributable to the shareholders of Semperit AG Holding
3) Values for 2014 and 2015 restated
Investor Presentation November 2016 I Investor Relations
32. Balance sheet structure: Assets
in EUR thousand 30/09/2016 31/12/2015
ASSETS
Non-current assets
Intangible assets 111,869 111,314
Tangible assets 301,059 276,630
Investments in joint ventures and associated
companies
109,270 102,670
Other financial assets 11,701 12,372
Other assets 7,367 5,275
Deferred taxes 14,066 16,717
555,331 524,978
Current assets
Inventories 133,303 135,711
Trade receivables 125,962 125,519
Other financial assets 5,518 2,284
Other assets 11,417 16,670
Current tax receivables 6,441 6,192
Cash and cash equivalents 131,456 126,430
414,097 412,806
TOTAL ASSETS 969,428 937,784
32 Investor Presentation November 2016 I Investor Relations
33. Balance sheet structure: Equity and liabilities
EQUITY AND LIABILITIES 30/09/2016 31/12/2015
Equity
Share capital 21,359 21,359
Capital reserves 21,503 21,503
Revenue reserves 312,332 317,733
Currency translation reserve 3,803 2,664
Equity attributable to shareholders of Semperit AG Holding 358,997 363,260
Non-controlling interests 1,892 1,924
360,890 365,183
Non-current provisions and liabilities
Provisions for pension and severance payments 44,006 40,775
Other provisions 9,840 11,421
Liabilities from redeemable non-controlling interests 48,274 44,192
Corporate Schuldschein loan 132,659 132,615
Liabilities to banks 208,259 162,898
Other financial liabilities 770 862
Other liabilities 1,001 746
Deferred taxes 9,556 11,924
454,365 405,433
Current provisions and liabilities
Provisions for pension and severance payments 3,091 2,866
Other provisions 13,094 19,033
Corporate Schuldschein loan 617 1,481
Liabilities to banks 6,046 5,560
Trade payables 93,976 100,660
Other financial liabilities 19,688 13,762
Other liabilities 14,408 19,037
Current tax liabilities 3,253 4,769
154,173 167,168
EQUITY AND LIABILITIES 969,428 937,784
in EUR thousand
33 Investor Presentation November 2016 I Investor Relations
34. Key figures 2008 – 2015
Key performance figures
in EUR m 2008 2009 20101)
20111)
2012 2013 20143)
20153)
Revenue 655.3 588.1 689.4 820.0 828.6 906.3 858.3 914.7
EBITDA 87.9 102.8 112.3 110.0 108.7 132.5 101.9 96.2
EBITDA margin 13.4% 17.5% 16.3% 13.4% 13.1% 14.6% 11.9% 10.5%
EBIT 58.7 69.6 82.3 80.4 72.5 87.8 63.8 66.7
EBIT margin 9.0% 11.8% 11.9% 9.8% 8.8% 9.7% 7.4% 7.3%
Earnings after tax 44.9 38.8 45.4 51.8 46.2 54.9 37.8 46.4
Earnings per share (EPS)2)
, in EUR 1.83 1.89 2.21 2.52 2.25 2.65 1.85 2.26
Gross cash flow 78.0 92.6 91.0 89.4 85.6 116.2 89.9 55.7
Return on equity 12.9% 12.5% 12.9% 13.6% 11.4% 13.3% 8.6% 12.8%
Balance sheet key figures
in EUR m 2008 2009 20101)
20111)
2012 2013 20143)
2015
Balance sheet total 485.5 531.5 593.5 616.7 824.5 852.1 826.3 937.8
Equity2)
291.9 310.6 351.1 379.4 406.2 411.5 443.8 363.3
Equity ratio 60.1% 58.4% 59.2% 61.5% 49.3% 48.3% 53.7% 38.7%
Investments in tangible and intangible assets 27.6 22.7 52.5 45.1 41.2 49.7 67.4 71.8
Employees (at balance sheet date) 7,064 6,649 7,019 8,025 9,577 10,276 6,888 7,053
1) Values for 2011 restated (see Annual Report 2012, Notes 2.18), values for 2010 not restated.
2) Attributable to the shareholders of Semperit AG Holding
3) Values for 2014 and 2015 restated
34 Investor Presentation November 2016 I Investor Relations
35. > 54%
> 5%
< 41%
B & C Holding Österreich GmbH, Vienna, Austria
FMR Co., Inc (Fidelity
Management & Research Company)
Free Float
Semperit is listed on the Vienna
Stock Exchange since 1890
Total of 20,573,434 shares with
a market capitalization of more than
EUR 500m (mid November 2016)
B & C Holding Österreich GmbH is part
of B & C Privatstiftung, an Austrian
based private foundation / trust
Primary focus of B & C is pursuing the
foundation’s mission to “foster Austrian
entrepreneurship”
Semperit benefits from a supportive
ownership structure with long-term
commitment from B & C
Fidelity Management and Research is
an American multinational financial
services corporation
Shareholder structure
Shareholder Structure
35 Investor Presentation November 2016 I Investor Relations